XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity and Noncontrolling Interests
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Stockholders' Equity and Noncontrolling Interests
NOTE 7: Stockholders' Equity and Noncontrolling Interests
Stockholders’ Equity
On May 10, 2023, our board of directors declared a dividend of $0.16 per share on our common stock, which was paid on July 21, 2023 to common stockholders of record as of June 30, 2023.
On March 14, 2023, our board of directors declared a dividend of $0.14 per share on our common stock, which was paid on April 21, 2023 to common stockholders of record as of March 31, 2023.
On May 18, 2022, our Board of Directors authorized a common stock repurchase program (the "Stock Repurchase Program") covering up to $250,000 in shares of our common stock. Under the Stock Repurchase Program, we, in our discretion, may purchase our shares from time to time in the open market or in privately negotiated transactions. The amount and timing of the purchases will depend on a number of factors, including the price and availability of our shares, trading volumes and general market conditions. The Stock Repurchase Program has no time limit and may be suspended or discontinued at any time. During the three and six months ended June 30, 2023, and 2022, we had no repurchases of shares under the Stock Repurchase Program. As of June 30, 2023, we had $250,000 in shares of our common stock remaining authorized for purchase under the Stock Repurchase Program.
On November 13, 2020, we entered into an equity distribution agreement pursuant to which we may have from time to time offered and sold shares of our common stock under our previous shelf registration statement having an aggregate offering price of up to $150,000 (the “Previous ATM Program”) in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"). Under the Previous ATM Program, we may also have entered into one or more forward sale transactions for the sale of shares of our common stock on a forward basis. There were no forward sale transactions that had not settled as of June 30, 2023 and no shares of our common stock were sold under the Previous ATM Program in the six months ended June 30, 2023.
On June 14, 2023, we replaced our previous shelf registration statement with our new shelf registration statement. Subject to market conditions, we intend to implement a new ATM program under the new shelf registration statement that would provide for offers and sales of shares of our common stock (including potentially on a forward sale basis) under our new shelf registration statement in negotiated transactions or transactions that are deemed to be "at the market" offerings as defined in Rule 415 under the Securities Act.
Noncontrolling Interest
During the three and six months ended June 30, 2023, holders of IROP units exchanged 0 and 144,600 units for 0 and 144,600 shares of our common stock, respectively. As of June 30, 2023, 5,946,571 IROP units held by unaffiliated third parties remain outstanding.
On May 10, 2023, our board of directors declared a dividend of $0.16 per IROP unit, which was paid on July 21, 2023 to IROP unit holders of record as of June 30, 2023.
On March 14, 2023, our board of directors declared a dividend of $0.14 per IROP unit, which was paid on April 21, 2023 to IROP unit holders of record as of March 31, 2023.